Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)
NCT00581425
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Basal Cell Carcinoma
Interventions
BIOLOGICAL:
Imiquimod and Interferon alpha
Sponsor
The University of Texas Health Science Center, Houston